# Evaluation of the Effect of AVE0657 in Cheynes-Stokes Breathing Syndrome Patients

> **NCT00694720** · PHASE2 · TERMINATED · sponsor: **Sanofi** · enrollment: 8 (actual)

## Conditions studied

- Heart Failure
- Sleep Apnea Syndromes
- Cheyne-Stokes Respiration

## Interventions

- **DRUG:** AVE0657
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00694720
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-06
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Termination following reassessment of the potential benefit-risk of AVE0657
- **Last updated:** 2009-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00694720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00694720, "Evaluation of the Effect of AVE0657 in Cheynes-Stokes Breathing Syndrome Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00694720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*